Hvilken er prisen på Hancock Jaffe Laboratories (HJLI)

Prisen på Hancock Jaffe Laboratories (HJLI) er $10.38

Hva er markedsverdien på Hancock Jaffe Laboratories (HJLI)

Markedsverdien på Hancock Jaffe Laboratories (HJLI) er $4.55M

Hancock Jaffe Laboratories (HJLI) Aksjesplitter

Hancock Jaffe Laboratories, Inc. is a medical device company in its developmental stage, specializing in creating advanced tissue-based and biologic solutions. These innovations are engineered to either sustain or significantly enhance the lives of patients afflicted with cardiovascular, peripheral arterial, and venous diseases, as well as end-stage renal disease (ESRD). The firm, headquartered in Irvine, California, maintains a dedicated team of nine full-time employees. Among its key initiatives, the company is actively developing implantable bioprosthetic devices for cardiovascular applications. This includes the Bioprosthetic Heart Valve (BHV), a swine-derived heart valve designed to mimic the function of a native heart valve and provide superior performance compared to current prosthetic options. Furthermore, the company is developing a Venous Valve, another bioprosthetic device sourced from pig tissue. This valve is specifically designed for individuals suffering from chronic venous insufficiency (CVI) in the lower limbs, a condition frequently resulting from damage to leg vein valves after the formation of deep venous blood clots.

År	Splitt	Multiplikator	Kumulativ multiplikator
Ikke nok data for de angitte datoene.

År

Splitt

Multiplikator

Kumulativ multiplikator

Ikke nok data for de angitte datoene.

Selskap	Antall aksjesplitt	Kumulativ multiplikator	Land
Abbott Laboratories ABT.US	9	x285	US
Stryker Corporation SYK.US	9	x162	US
Medtronic plc MDT.US	7	x127	IE
Boston Scientific Corporation BSX.US	2	x4	US
Edwards Lifesciences Corporation EW.US	3	x12	US

Selskap

Antall aksjesplitt

Kumulativ multiplikator

Land